Top 50 Life Science Startup Investors in Spain (July 2026)

Portfolio highlights

• Xoople — Xoople operates as an earth intelligence company. Xoople powers the next generation of Earth data intelligence to achieve a systematic understanding of physical changes on the Earth’s surface.
• Orga AI — Organ AI creates generative artificial intelligence that will help people. Its headquarters is located in Palma De Mallorca, Islas Baleares, Spain.
• Golden Owl —

Portfolio highlights

• DYNAMICS VR — Dynamics VR provides rehab software for clinics to tackle musculoskeletal pain and movement impairments caused by brain trauma.
• Axoltis Pharma — Axoltis Pharma is a biotech company that develops drugs for degenerative and traumatic neurological disorders.
• EVis Bioscience — EVis Bioscience offers gene delivery solutions using extracellular vesicles, lipid nanoparticles, and hybrid systems.

Portfolio highlights

• FlexiiC — FlexiiC is a deep-tech firm developing printed, flexible integrated circuits for sustainable IoT and smart packaging solutions.
• Bioherent — Photonic biosensors for drug allergy diagnosis
• Impetux Optics — IMPETUX develops and markets patented technology to characterise the mechanical properties of living tissues and cells. We are focusing the application of our technology in fields like Mechanobiology where the study of diseases directly related with cell migration or development are demanding new techniques. We offer cutting-edge non-invasive to...

Portfolio highlights

• Orikine Bio — Orikine Bio is a pioneer biotech company in the field of tailored cytokines with unmatched biological properties for the treatment of immune-mediated disorders.
• Splice Bio — Splice Bio is a gene therapy company based on technology developed in the Muir Lab at Princeton University. The company is developing novel gene therapies based on its proprietary intein platform technology to treat patients that suffer from incurable genetic diseases. The company’s platform has the potential to address two existing limitations ofadeno-associated viruses (AAVs), both by increasing the size of the cargo gene that can be delivered and by expanding the range of tissues that can be targeted.
• Ona Therapeutics — Ona Therapeutics is a biotech company that specializes in the discovery and development of therapeutic biologics targeting tumor metastatic-initiating cells and lipid metabolism. Founded in 2019 by Salvador Aznar-Benitah and Valerie Vanhooren, it was a spin-off from ICREA and Advanced Studies, and the IRB Institute for Research in Biomedicine.

Portfolio highlights

• ARTHEx Biotech — ARTHEx Biotech S.L. is a spin-off company of the University of Valencia that is developing advanced RNA treatments against genetic diseases.
• Gyala Therapeutics — Gyala Therapeutics is focused on developing new CAR-T therapies for treating hematological malignancies. CAR-T (chimeric antigen receptor T cells) is a type of gene therapy in which T lymphocytes -a type of white blood cells that play a key role in immune responses- are extracted from the patient and modified to attack tumour cells. T lymphocytesare obtained through apheresis (a technique that allows separation of blood components) and genetically reprogrammed with a receptor that binds to a tumor factor. When these cells are transduced back to the patient, they are to specifically recognize tumour cells and attack them. Several types of CAR-T cells have demonstrated efficacy in the treatment of leukemias and B cell lymphomas.
• Telomere Therapeutics — Telomere Therapeutics is a University of Barcelona spinoff developing telomerase gene therapy to treat pulmonary fibrosis

Portfolio highlights

• MOA — MOA make healthy food for a sustainable world that solves growing global food demands. They are establishing a new industry of sustainable food that solves growing global food demands without the need for arable land. They are focused on designing high-value, natural and nutritious food.
• Zoundream — The Future of Infant Care
• Ona Therapeutics — Ona Therapeutics is a biotech company that specializes in the discovery and development of therapeutic biologics targeting tumor metastatic-initiating cells and lipid metabolism. Founded in 2019 by Salvador Aznar-Benitah and Valerie Vanhooren, it was a spin-off from ICREA and Advanced Studies, and the IRB Institute for Research in Biomedicine.

Portfolio highlights

• Aortyx — With a focus on aortic dissection, Aortyx has developed a bioresorbable endovascular patch designed to seal the entry tear, delivered through a proprietary dual-steerable catheter.
• MiMARK — MiMARK focuses on improving the accuracy and efficiency of diagnostics for endometrial cancer, which is the sixth most commonly occurring cancer in women.1 As with many cancers, early and accurate detection of the disease is linked to increased survival, however currently around a third of endometrial cancer patients are diagnosed at the advancedstage.2 By improving the technology available for the diagnosis of endometrial cancer, MiMARK hopes to improve the speed and accuracy at which women can be diagnosed and effectively treated.
• Neboda — We are an indoor vertical farming company that combines combines a scientific approach and an industrial automation background.

Portfolio highlights

• TucanPay — TucanPay is a money transfer platform that sends money between continents.
• Biotasmart —
• DARWIN Biomed — Biomedical Engineering

Portfolio highlights

• AM Pharma — AM-Pharma B.V., a biopharmaceutical company, engages in the development and commercialization of therapeutics for human use in the Netherlands. It focuses in the pre-clinical and clinical development of novel therapeutics to treat inflammatory and infectious diseases. The company develops products based on endogenous proteins and protein derivedpeptides, as well as molecules that naturally occur in the human body. Its products include alkaline phosphatase for treatment of acute kidney injury and ulcerative colitis; and immune response amplifying peptide hLF1-11 for the treatment of drug resistant hospital acquired infections. The company was founded in 2000 and is headquartered in Bunnik, the Netherlands.
• Splice Bio — Splice Bio is a gene therapy company based on technology developed in the Muir Lab at Princeton University. The company is developing novel gene therapies based on its proprietary intein platform technology to treat patients that suffer from incurable genetic diseases. The company’s platform has the potential to address two existing limitations ofadeno-associated viruses (AAVs), both by increasing the size of the cargo gene that can be delivered and by expanding the range of tissues that can be targeted.
• Synendos Therapeutics — Synendos Therapeutics is a biopharmaceutical company that aims to develop breakthrough safe and effective therapies for unmet needs in neuropsychiatric disorders through modulation of a new drug target in the endocannabinoid system that enables restoration of natural functioning of the brain.

Portfolio highlights

• Qrem —
• Shapelets — Shapelets optimizes GenAI and data visualization with advanced vector databases and agile tools for data professionals
• Wagmi Venture Studio — Wagmi VS is creating transformative web3 experiences that democratize opportunity and ownership of the internet.

Portfolio highlights

• DeepUll — DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition. DeepUll’s proposal is based on quickly identifying the pathogens and offering the antibiogram within a few hours on the one hand, and on using the data and learning about the patient’s immunological and functionalstatus on the other. The system allows doctors to predict the future appearance and evolution of sepsis within a short period of time and thus provide a suitable clinical response even before the symptoms arise.
• Peptomyc — Peptomyc is a company focused on the development of a new generation of cell-penetrating peptides (CPPs) targeting the Myc oncoprotein for cancer treatment. The company was founded in December 2014 and it is based on Dr. Soucek’s scientific research in Omomyc (the best direct Myc inhibitor known to date) over the last twenty years.Currently,cancer incidence in the world exceeds 14 million cases per year and results in 8 million deaths annually. Moreover, such numbers are forecast to rise by 75% over the next 20 years (World Cancer Report. International Agency for Research on Cancer 2014). At the moment, standard therapies include surgery, radiotherapy, chemotherapy, and, in a restricted subset of cancers, precision medicine. Unfortunately, very often these therapies fail, due to the development of resistance.Peptomyc has adopted a different strategy based on the inhibition of the oncoprotein Myc, which is found deregulated in the majority of human cancers. Myc holds a non-redundant function in cancer around which tumors cannot evolve, hence targeting Myc is the most promising therapeutic opportunity to date. Although Myc plays a central role in cancer there is currently no Myc inhibitor in the market.
• Ona Therapeutics — Ona Therapeutics is a biotech company that specializes in the discovery and development of therapeutic biologics targeting tumor metastatic-initiating cells and lipid metabolism. Founded in 2019 by Salvador Aznar-Benitah and Valerie Vanhooren, it was a spin-off from ICREA and Advanced Studies, and the IRB Institute for Research in Biomedicine.

Portfolio highlights

• Facility — Flexkeeping is a Hotel Operations Platform designed to help teams automate and collaborate like never before.
• ForTunes — ForTunes puts comprehensive data analytics at the fingertips of millions of music creators. Serving the new generation of artists, producers & their representatives.
• GAMINSIDE — GAMINSIDE revolutionizes your relationship with your customers. As European full service provider, we deliver the complete package with solutions, services and software for gamified loyalty that is tailor-made and unique to your products, brands and customers. Integrate the best ideas from gamification and customer loyalty in your business areato exceed your commercial targets with GAMINSIDE.

Portfolio highlights

• Tenzo — Tenzo is a restaurant analytics and AI forecasting platform for restaurants, pubs and cafes. Tenzo makes running restaurants easy with full data visibility.
• Slamcore — Positioning, mapping and perception | State-of-the-art visual SLAM turns sensor data into actionable, spatial understanding for your vehicles.
• Unifyr — IDC MarketScape Leader 2025. AI-native PRM platform for partner onboarding, enablement, deal registration, and through-channel marketing.

Portfolio highlights

• Zigazoo — Zigazoo is the leader in children's short-form video. On Zigazoo, kids make creative video responses to fun challenges and share them with friends.They are American parents and teachers who get their inspiration from children and believe in the power of kid creations. Hailed as "a smarter screen-time activity" by TechCrunch andlauded by children’s media advocacy organizations for its safety, Zigazoo enables kids to share video responses to challenges built by leading museums, zoos, educators, and media stars.
• Construyo — Construyo is a holistic service provider in the area of construction planning. Through the company’s network of partners and its bespoke management platform, every stage of the project from quotes to contracts, designs, plans and engineering certificates can be accessed in one single, secure place, by everyone involved.
• Beyond — Write your will online, apply for probate or arrange a meaningful funeral.

Portfolio highlights

• Bianalisi — Bianalisi provides services that include toxicological examination of the hair, diagnostic imaging, specialised examinations, laboratory analysis, physiotherapy and rehabilitation, occupational medicine, and more. They offer diagnostic services.
• UNIVERSAE — UNIVERSAE offers vocational training services.
• Veritas Intercontinental — Our test based on whole exome and genome sequencing provides the interpretation of extensive genetic information that can be further analyzed in the future.

Portfolio highlights

• Barbara — Barbara is the Cybersecure Industrial Edge Platform that enables companies to connect, deploy and scale gateways and edge applications in a few clicks
• Minoryx Therapeutics — Minoryx is focused on the discovery and development of novel treatments for severe, orphan diseases of the central nervous system with high unmet medical need.
• iPronics — iPronics develops the innovative concepts of general-purpose integrated programmable photonic systems.

Portfolio highlights

• Tornado — Digest information from thousands of public filings and your own documents with a versatile AI analyst, plus the reliability of full source attribution.
• Dispersa — Harnessing the power of microbe-derived natural solutions to decarbonize the chemicals industry.
• Opalia — Opalia is introducing a new era of dairy: functional, delicious, and sustainable dairy made from mammary cells.

Portfolio highlights

• NRG Therapeutics — energizing drug discovery in neurodegenerative diseases.
• Adaptam Therapeutics — Adaptam Therapeutics is at the forefront of next-generation cancer immunotherapies
• Cytospire Therapeutics — Cytospire Therapeutics is bringing forward a portfolio of next generation immune cell engagers.

Portfolio highlights

• Ona Therapeutics — Ona Therapeutics is a biotech company that specializes in the discovery and development of therapeutic biologics targeting tumor metastatic-initiating cells and lipid metabolism. Founded in 2019 by Salvador Aznar-Benitah and Valerie Vanhooren, it was a spin-off from ICREA and Advanced Studies, and the IRB Institute for Research in Biomedicine.
• Tubulis — Reimagining Antibody Drug Conjugates Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and
• TargED Biopharmaceuticals — TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.TargED stands for Targeted Enzyme Delivery. Their biological drugs are unique by using small antibodies (“VhH”) to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis.

Portfolio highlights

• TietAI — TietAI builds healthcare data interoperability infrastructure for hospitals, research networks and life sciences. The platform, Hydra, is split into two products. Hydra Connects is non-medical-device middleware for clinical data exchange across HL7v2, FHIR, DICOM, OMOP, X12 and CDA. Hydra Agentic is a high-risk AI system under the EU AI Act,designed for clinical agentic workflows.
• Energiot — Energiot specialized engineering service in energy harvesting, self-powered devices, wireless sensor networks.
• Floatech — Discover Floatech: Boosting lithium-ion batteries with sustainable, high-performance silicon anodes. Explore our innovative technology.

Portfolio highlights

• AtG Therapeutics — At AtG, we develop new drugs and biomarkers to stop cancer metabolic adaptation.
• NIMBLE Diagnostics — NIMBLE Diagnostics is a technological organization that develops and provides services related to biotechnology research activities.

Portfolio highlights

• Algorized — Algorized develops advanced technologies for human presence detection using UWB Radar.
• Ratio — A new way to finance subscription companies without dilution offering flexibility to help you thrive and compete. Put your recurring revenue to work.
• Scout AI — Scout AI is building the robotic foundation model for defense.

Portfolio highlights

• Kreios Space — Kreios Space is developing an electric propulsion system to revolutionize the satellite industry. With this technology we enable orbital keeping in VLEO (Very Low Earth Orbits) thanks to renewable energy. We make space applications easier.
• VigSec-Drone — VigSec-Drone is a high-performance security and surveillance designed to deliver real-time situational awareness.
• Iteria Biopharma — Iteria Biopharma focused on discovering and developing precision oncology drugs, particularly first-in-class new chemical entities (NCEs) for challenging cancer targets with high unmet medical needs.

Portfolio highlights

• OneChain Immunotherapeutics — CAR-T Immunotherapies against hematological malignancies

Portfolio highlights

• D-Sight — D-Sight is an early treatment for the leading cause of preventable blindness in the working-age population.
• Pharmacelera — Improving pharmaceutical R+D productivity through a lean drug discovery process based on advanced computational methodologies.
• BQC Redox Technologies — Assay kits and devices for rapid and easy quantification of REDOX parameters or biomarkers

Portfolio highlights

• Tirecat — Tirecat specialized in developing sophisticated tissue regeneration treatments to combat chronic and terminal diseases.
• NSS Water —
• The Blue Box Biomedical Solutions — Pain-free, low-cost, sensitive, radiation-free device to detect breast cancer in urine

Portfolio highlights

• Molecular Gate — Molecular Gate refer to an innovative class of small-molecule drugs developed by Gate Bioscience. These drugs target the secretory translocon (Sec61 channel) in cells to selectively block and degrade harmful extracellular proteins before they can be secreted and cause disease.
• Bioinspired Materials — Bioinspired Materials is a Biotech-based entrepreneurship project with the participation of the Universitat Pompeu Fabra. The company develops wastewater valorization that produces biological products of high value in the market. BIOM was founded in 2019 and is based in Barcelona, Spain.
• Ars Magna Semiconductors — Ars Magna Semiconductors develops semiconductor chips designed for decentralized artificial intelligence applications. The company's technology operates with low energy consumption, real-time processing, and enhanced data privacy by reducing the number of operations and hardware requirements. Their chips address the global semiconductorshortage while enabling more efficient AI processing with reduced computational overhead.

Portfolio highlights

• Calibre — Calibre uses causal AI in conjunction with clinical expertise to help people understand what is truly influencing their health and how to modify it.
• Modern Relay — Modern Relay provides context graph for enterprise AI.
• Theorema — Autonomous R&D agents for biotech, pharma, chemicals, and materials. Theorema analyzes data, recovers R&D costs, and accelerates discovery. #1 on BixBench.

Portfolio highlights

• Rauda AI — Rauda is an artificial intelligence platform specialized in automating customer service with the best customer experience. Take a quantum leap in productivity, reduce costs and improve customer satisfaction with the power of generative artificial intelligence.
• Aino — AI-powered site analysis for real estate professionals. Generate feasibility studies with quantified metrics, maps, cost estimates, and zoning insights in minutes, no GIS or coding required.
• Orbital Paradigm —

Portfolio highlights

• Inspide — Understand all the information in the real world and make it actionable
• FYLA — At FYLA we create unique All-fiber Ultrafast pulsed lasers by Joining Singularity with Quality. Discover our multiphoton and two photon lasers!
• 2Eyes Vision — 2EyesVision is a start-up (CSIC spin-off) specialized in the creation, development, and commercialization of novel ophthalmic technologies.

Portfolio highlights

• Capital Cell — Capital Cell is a crowdinvesting platform for biotech and life sciences companies. Mixing VC, business angels, accredited investors, and the power of the crowd, the company is building a global meeting point for companies and researchers working, fostering, and financing tomorrow’s medical science.

Portfolio highlights

• Tines — Tines is an enterprise automation platform designed to help security and ops teams automate manual workloads. With 1,000+ template options for common security actions, Tines is power and simplicity through direct integration with your existing tools. The company was founded in 2018 and is headquartered in Dublin.
• Hello Vet — Same-day vet appointments, emergency care & calm clinics across London. Find trusted veterinary care with Hello Vet.
• Modern Animal — Modern Animal is an innovative veterinary platform building a new kind of veterinary experience for animals and humans. The veterinary platform offers unlimited exams, in-app prescription requests & delivery, 24/7 virtual care, and more. They build innovations in technology and design give you greater access to a team of experts,flexibility, and convenience in every interaction, and the highest level of personalized care.Modern Animal built the next generation in veterinary care, reshaping a traditional industry to better meet the needs of pet owners, pets, practitioners and staff. Through the state-of-the-art app and in-clinic technology and design, as well as a membership model that allows for quality relationships to develop between doctors, pets and pet owners.Modern Animal was founded in 2019 and is headquartered in Los Angeles, California, USA.

Portfolio highlights

• Thytech — Thytech is a health tech company.
• Affirma Biotech — Affirma Biotech develops new orally available immunotherapeutic drugs for the treatment of severe infections and cancer
• Ownmed Innovation — Ownmed Innovation is a Medtech spin-off that emerged from the collaboration between the Fundación para la Investigación Biomédica Hospital Gregorio Marañón (FIBHGM), the Instituto Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD) and Universidad Carlos III de Madrid (UC3M). Its main objective is the development of a medical device, Ostofix®,aimed at ostomate patients, with the purpose of restoring their ability to regain control over their continence.

Portfolio highlights

• Pago — Managing and paying utility bills, insurance, mobile top-ups and taxes takes too much time for many households in Europe. Pago simplifies these payments by adding automation where possible, using integrations with billers, insurers and online platforms to dramatically reduce the time needed for all these payments. The service is available in theB2C app called Pago and through B2B integrations by embedding Pago features in partner apps through SDK or API. Pago's services are used by over 500k monthly active users in Romania, Poland and Italy.
• Brainactive — Brainactive is an AI-driven platform that streamlines the access to vital insights used by companies to make sound business decisions, by enabling them to directly interview their current and potential customers, regardless of their expertize in sociology, past experience with market research, size of their team, or their market research budget.Integrated with a pool of 300+ million vetted and engaged consumers around the world, the platform allows companies to get relevant answers to their questions in minutes, with assistance from advanced conversational and generative LLM trained on market research, available along the way.Putting businesses in direct contact with their customers essentially removes the need for any intermediaries in the process and brings the costs and time down to a mere fraction of what traditional market research typically requires. At the same time, companies get to keep sensitive concepts and prototypes tested entirely secured, since no one else is involved, at any stage.
• dotLumen - Empowering the Blind — .lumen builds glasses that help the blind live a better life.

Portfolio highlights

• Exoticca — Exoticca develops an online platform intended to facilitate travel booking. The company's platform offers holiday packages which includes flights, accommodation, meals, guides and private transports, for exotic locations all around the world, enabling travelers to book travel packages online at competitive prices.
• Harmonix — Harmonix is a software development company that uses AI for CRM to communicate with customers to send email, calls, and SMS.
• AtG Therapeutics — At AtG, we develop new drugs and biomarkers to stop cancer metabolic adaptation.

Portfolio highlights

• Aniling — Aniling developing its worldwide patent of the second generation genomic analysis and epigenomic.
• Petoons Studio — Petoons Studio is a developer of transmedia projects startup.
• The Smart Lollipop — The Smart Lollipop is a non-intrusive medical device in the shape of a lollipop with the goal to detect diseases with a single saliva sample.

Portfolio highlights

• Neuroute —
• Altis Labs — Altis Labs is the computational imaging company advancing precision medicine. We believe that medical imaging is the richest source of untapped information. Life sciences companies use our software platform, Nota, to accelerate all stages of clinical development. Trained on over 140 million longitudinal real-world images with associated clinicalinformation, our deep learning models predict clinically meaningful outcomes to quantify treatment effect more accurately.
• VeriSIM Life — Make confident decisions about drug development, quickly and efficiently, using a decision-engine that takes your toughest translational questions and generate actionable insights to guide your next steps.

Portfolio highlights

• Affirma Biotech — Affirma Biotech develops new orally available immunotherapeutic drugs for the treatment of severe infections and cancer

Portfolio highlights

• Affirma Biotech — Affirma Biotech develops new orally available immunotherapeutic drugs for the treatment of severe infections and cancer

Portfolio highlights

• Libre Foods — MEAT, BUT MAKE IT MUSHROOMS. GET READY TO TASTE THE POWER OF FUNGI
• Cosaic — Cultivated - Creamy, dairy-free indulgence

Portfolio highlights

• Bosque Foods — Kinoko Labs develops the next generation of meat substitutes, starting with whole-cut meat items made from fungal mycelium produced organically. Headquartered in New York.
• Libre Foods — MEAT, BUT MAKE IT MUSHROOMS. GET READY TO TASTE THE POWER OF FUNGI
• Kynda — Keen 4 Greens offers a wide range of vegan products. Founded in 2019, Keen 4 Greens is based in Hamburg, Germany.

Portfolio highlights

• Libre Foods — MEAT, BUT MAKE IT MUSHROOMS. GET READY TO TASTE THE POWER OF FUNGI

Portfolio highlights

• Lovely Day Foods — We harness the power of plants and cutting-edge technology to crack the egg.
• Libre Foods — MEAT, BUT MAKE IT MUSHROOMS. GET READY TO TASTE THE POWER OF FUNGI
• Nosh Biofoods — We create nutritional and highly functional proteins from non-GMO fungi. Our proprietary ferementation process is minimal, scalable, and sustainable.

Portfolio highlights

• MOA — MOA make healthy food for a sustainable world that solves growing global food demands. They are establishing a new industry of sustainable food that solves growing global food demands without the need for arable land. They are focused on designing high-value, natural and nutritious food.
• Ojer Pharma — Ojer Pharma engages in the research, development, production, and marketing of dermopharmaceutical products in Spain. It develops prescription medicines, cosmetics, and medical devices. The company has developed a vehiculization technology in the form of bioadhesive transparent gels, which acts as a sustained-release matrix of dermatologicalactives, such as lipophilics and hydrophilics.
• Semi Zabala — Welcome to Semi Zabala, a pioneering semiconductor company dedicated to innovation and excellence. Our mission is to push boundaries and enhance technology, embodying our slogan: beyond the power. Explore our advanced solutions designed for a smarter, more connected future.

Portfolio highlights

• Nutropy — Nutropy produces real milk ingredients, identical to those produced by cows, to develop premium cheese alternatives that taste just as good as cow’s cheese but are more sustainable, healthier and better for the animals. No animals involved, full cheese experience.
• Purezza — The best vegan pizza restaurant and plant-based Italian menu. Purezza has restaurants in Brighton, London (Camden) and Manchester.
• SHICKEN Foods — Plant-based chicken manufacturer

Portfolio highlights

• Poseidona — We provide sustainable protein ingredients from seaweed side-streams and invasive algae so manufacturers can develop the tastiest food products.
• Quazy Foods — Quazy Foods unleashes the power of microalgae for healthy, sustainable, and competitive functional ingredients.
• Cultimate Foods — At Cultimate, we are transforming the flavor and aroma industry with natural innovative ingredients.

Portfolio highlights

• SonoThera — Explore therapeutic ultrasound for non-invasive, targeted genetic medicine delivery that improves precision and biodistribution. Learn more.
• Splice Bio — Splice Bio is a gene therapy company based on technology developed in the Muir Lab at Princeton University. The company is developing novel gene therapies based on its proprietary intein platform technology to treat patients that suffer from incurable genetic diseases. The company’s platform has the potential to address two existing limitations ofadeno-associated viruses (AAVs), both by increasing the size of the cargo gene that can be delivered and by expanding the range of tissues that can be targeted.
• Neurona Therapeutics — Neurona Therapeutics is a pre-clinical stage biotechnology company that was founded by four neuroscientists and stem cell pioneers at The University of California, San Francisco. They are focused on the discovery and development of cell-based therapies to treat intractable neurological disease. Its initial aim is to generate therapeuticcompositions of a specific type of nerve cell (or neuron) for targeted delivery into the injured nervous system. Based on nearly two decades of research, they believe that particular subpopulations of neurons have the unique ability to integrate and repair dysregulated neural circuits. Its talented team of scientists, scientific advisors, and board directors is working to accelerate breakthrough treatments for patients with significant unmet medical needs.

Portfolio highlights

• IonQ — Working to build the world's best quantum computers to solve the world's most complex problems
• Spyglass Ophthalmics — A vision towards a higher quality of life!
• Xenon Pharmaceuticals — A leading neuroscience company forging new paths for those living with neurological and psychiatric disorders.

Portfolio highlights

• Cafler — Your car's personal assistant. Ask for a Cafler now, we move your car for you!
• Amelia Virtual Care — Psious develops a virtual reality platform designed to bring value to mental health treatment. The company's platform uses hyper-realistic virtual environments to treat anxiety disorders by means of virtual exposure therapy, enabling professionals to improve mental health therapies.
• NH Hoteles — NH Hotel Group is a consolidated travel and leisure hotel operator. It is one of the top 25 hotel chains in the world and one of the main ones in Europe, currently operating close to 400 hotels with almost 60,000 rooms in 31 countries in Europe, America, and Africa.

Portfolio highlights

• Seqera — Seqera Labs is a Barcelona-based business creating solutions for high-performance computing workloads across cloud and clusters. It was founded by the creators of the popular open-source workflow software Nextflow (http://www.nextflow.io).